SMART-101 is under clinical development by Smart Immune and currently in Phase II for Relapsed Acute Myeloid Leukemia.

QL-401 is under clinical development by QLSF Biotherapeutics and currently in Phase I for Refractory Acute Myeloid Leukemia.

Interesting trends were observed in the subgroup analyses of the phase 3 uproleselan study in relapsed or refractory acute ...

The British wife of ousted Syrian dictator Bashar al-Assad is deathly ill with leukemia — with doctors only giving her a 50% ...

A workaholic doctor thought her extreme back pain was just stress-related when she was diagnosed with acute myeloid leukaemia ...

The holidays can be especially tough for cancer patients, but two best friends are making the best of it by supporting each ...

Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

The family drama surrounding fallen Syrian dictator Bashar al-Assad took a new twist Thursday as his wife was reported to be ...

Eunice S. Wang, MD, discusses a retrospective study of 105 patients diagnosed with secondary acute myeloid leukemia.

The wife of former Syrian President Bashar Assad, Asma, is experiencing a relapse of leukemia (an oncological malignant blood ...

Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with ...